Cite

HARVARD Citation

    Langford, C. et al. (2017). A Randomized, Double‐Blind Trial of Abatacept (CTLA‐4Ig) for the Treatment of Takayasu Arteritis. Arthritis & rheumatology. 69 (4), pp. 846-853. [Online]. 
  
Back to record